The concept of circulating tumor DNA-based next-generation sequencing analyses will revolutionize the management of cancer patients with potentially curable or metastatic disease.""...progress in management of patients with advanced and metastatic cancer remains modest over the last decade.
No takes yet. Share an insight, caveat, or question.
Lianos et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: